#USA #New York #BMO Financial #Metabolic Health #GLP-1 Therapy

BMO Capital Markets to Host Metabolic Health Summit 2026

On March 24, 2026, BMO Capital Markets will host its highly anticipated Metabolic Health Summit in New York City, marking the transition from its previous Obesity Summit. This annual gathering convenes thought leaders across the healthcare landscape to discuss critical advancements in the fields of metabolic health, cardiovascular science, and GLP-1—an innovation that shows promise in addressing various medical conditions ranging from obesity to diabetes, heart failure, and renal health.

Purpose of the Summit

The 2026 Metabolic Health Summit aims to explore the evolving landscape of metabolic disease therapies and the implications of GLP-1 innovations. With healthcare professionals, investors, and BioPharma innovators in attendance, the day consists of panels, fireside chats, and opportunities for one-on-one discussions. This enriching environment encourages collaboration and sharing of insights on the future of metabolic health.

Event Details

The Metabolic Health Summit will take place on Tuesday, March 24, 2026, from 7:30 a.m. to 4:30 p.m. ET at the Westin Grand Central in New York, located at 212 E 42nd St. Notably, this event is in-person only, fostering direct engagement and networking among attendees.

Notable Discussions

Attendees can look forward to:

• - Fireside chats with BMO analysts and prominent leaders from major life sciences companies such as Aardvark Therapeutics, Amgen, Eli Lilly, Novo Nordisk, Pfizer, and Structure Therapeutics.
• - A specialized session titled "Obesity 103" by Dr. Katherine Saunders, a leading expert in obesity medicine.
• - An enlightening discussion on the State of Obesity Medicine in 2026 featuring Dr. Louis J. Aronne, M.D., from Weill Cornell Medical College.
• - Panels addressing care delivery, emerging technologies, and insights from organizations like WeightWatchers, Metaphore Biotechnologies, Virta Health, and more.
• - Valuable insights gathered directly from patients undergoing GLP-1+ therapy, shedding light on real-world experiences and outcomes.

About BMO Financial Group

With a strong legacy spanning over 200 years, BMO Financial Group is recognized as the eighth largest bank in North America, boasting total assets of $1.5 trillion as of January 31, 2026. The company's mission is to "Boldly Grow the Good in business and life," driving positive change and commitment towards creating a sustainable future and thriving communities. BMO provides diverse services, supporting approximately 13 million clients across North America and other select global markets.

For further information regarding the summit or to connect with BMO's equity research analysts, media personnel can reach out to BMO Media Relations. Please note that there may be access restrictions for certain presentations during the event. This year’s event consolidates BMO’s commitment to elucidate and advance understanding within the ecosystem of metabolic health and GLP-1 therapies.